Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bermúdez-Humarán LG[au]:

Search results

Items: 1 to 50 of 98

1.

Oral delivery of pancreatitis-associated protein by Lactococcus lactis displays protective effects in dinitro-benzenesulfonic-acid-induced colitis model and is able to modulate the composition of the microbiota.

Breyner NM, Vilas Boas PB, Fernandes G, de Carvalho RD, Rochat T, Michel ML, Chain F, Sokol H, de Azevedo M, Myioshi A, Azevedo VA, Langella P, Bermúdez-Humarán LG, Chatel JM.

Environ Microbiol. 2019 Nov;21(11):4020-4031. doi: 10.1111/1462-2920.14748. Epub 2019 Sep 10.

PMID:
31325218
2.

From Probiotics to Psychobiotics: Live Beneficial Bacteria Which Act on the Brain-Gut Axis.

Bermúdez-Humarán LG, Salinas E, Ortiz GG, Ramirez-Jirano LJ, Morales JA, Bitzer-Quintero OK.

Nutrients. 2019 Apr 20;11(4). pii: E890. doi: 10.3390/nu11040890. Review.

3.

The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response.

Martín R, Chamignon C, Mhedbi-Hajri N, Chain F, Derrien M, Escribano-Vázquez U, Garault P, Cotillard A, Pham HP, Chervaux C, Bermúdez-Humarán LG, Smokvina T, Langella P.

Sci Rep. 2019 Apr 1;9(1):5398. doi: 10.1038/s41598-019-41738-5.

4.

Anti-tumoral Effects of Recombinant Lactococcus lactis Strain Secreting IL-17A Cytokine.

Jacouton E, Torres Maravilla E, Boucard AS, Pouderous N, Pessoa Vilela AP, Naas I, Chain F, Azevedo V, Langella P, Bermúdez-Humarán LG.

Front Microbiol. 2019 Jan 23;9:3355. doi: 10.3389/fmicb.2018.03355. eCollection 2018.

5.

Elucidating the Immune-Related Mechanisms by Which Probiotic Strain Lactobacillus casei BL23 Displays Anti-tumoral Properties.

Jacouton E, Michel ML, Torres-Maravilla E, Chain F, Langella P, Bermúdez-Humarán LG.

Front Microbiol. 2019 Jan 11;9:3281. doi: 10.3389/fmicb.2018.03281. eCollection 2018.

6.

A New Bifidobacteria Expression SysTem (BEST) to Produce and Deliver Interleukin-10 in Bifidobacterium bifidum.

Mauras A, Chain F, Faucheux A, Ruffié P, Gontier S, Ryffel B, Butel MJ, Langella P, Bermúdez-Humarán LG, Waligora-Dupriet AJ.

Front Microbiol. 2018 Dec 21;9:3075. doi: 10.3389/fmicb.2018.03075. eCollection 2018.

7.

Phosphatidylglycerols are induced by gut dysbiosis and inflammation, and favorably modulate adipose tissue remodeling in obesity.

Kayser BD, Lhomme M, Prifti E, Da Cunha C, Marquet F, Chain F, Naas I, Pelloux V, Dao MC, Kontush A, Rizkalla SW, Aron-Wisnewsky J, Bermúdez-Humarán LG, Oakley F, Langella P, Clément K, Dugail I.

FASEB J. 2019 Apr;33(4):4741-4754. doi: 10.1096/fj.201801897R. Epub 2019 Jan 4.

8.

M cell-targeting strategy enhances systemic and mucosal immune responses induced by oral administration of nuclease-producing L. lactis.

Takahashi K, Yano A, Watanabe S, Langella P, Bermúdez-Humarán LG, Inoue N.

Appl Microbiol Biotechnol. 2018 Dec;102(24):10703-10711. doi: 10.1007/s00253-018-9427-1. Epub 2018 Oct 11.

PMID:
30310964
9.

Live bacterial biotherapeutics in the clinic.

Bermúdez-Humarán LG, Langella P.

Nat Biotechnol. 2018 Sep 6;36(9):816-818. doi: 10.1038/nbt.4248. No abstract available.

PMID:
30188536
10.

Increased gut permeability in cancer cachexia: mechanisms and clinical relevance.

Bindels LB, Neyrinck AM, Loumaye A, Catry E, Walgrave H, Cherbuy C, Leclercq S, Van Hul M, Plovier H, Pachikian B, Bermúdez-Humarán LG, Langella P, Cani PD, Thissen JP, Delzenne NM.

Oncotarget. 2018 Apr 6;9(26):18224-18238. doi: 10.18632/oncotarget.24804. eCollection 2018 Apr 6.

11.

A Versatile New Model of Chemically Induced Chronic Colitis Using an Outbred Murine Strain.

Barone M, Chain F, Sokol H, Brigidi P, Bermúdez-Humarán LG, Langella P, Martín R.

Front Microbiol. 2018 Mar 27;9:565. doi: 10.3389/fmicb.2018.00565. eCollection 2018.

12.

Searching for the Bacterial Effector: The Example of the Multi-Skilled Commensal Bacterium Faecalibacterium prausnitzii.

Martín R, Bermúdez-Humarán LG, Langella P.

Front Microbiol. 2018 Mar 6;9:346. doi: 10.3389/fmicb.2018.00346. eCollection 2018.

13.

Bile Salt Hydrolase Activities: A Novel Target to Screen Anti-Giardia Lactobacilli?

Allain T, Chaouch S, Thomas M, Travers MA, Valle I, Langella P, Grellier P, Polack B, Florent I, Bermúdez-Humarán LG.

Front Microbiol. 2018 Feb 8;9:89. doi: 10.3389/fmicb.2018.00089. eCollection 2018.

14.

Bile-Salt-Hydrolases from the Probiotic Strain Lactobacillus johnsonii La1 Mediate Anti-giardial Activity in Vitro and in Vivo.

Allain T, Chaouch S, Thomas M, Vallée I, Buret AG, Langella P, Grellier P, Polack B, Bermúdez-Humarán LG, Florent I.

Front Microbiol. 2018 Jan 31;8:2707. doi: 10.3389/fmicb.2017.02707. eCollection 2017.

15.

Probiotic Strain Lactobacillus casei BL23 Prevents Colitis-Associated Colorectal Cancer.

Jacouton E, Chain F, Sokol H, Langella P, Bermúdez-Humarán LG.

Front Immunol. 2017 Nov 17;8:1553. doi: 10.3389/fimmu.2017.01553. eCollection 2017.

16.

New Insights into the Diversity of the Genus Faecalibacterium.

Benevides L, Burman S, Martin R, Robert V, Thomas M, Miquel S, Chain F, Sokol H, Bermudez-Humaran LG, Morrison M, Langella P, Azevedo VA, Chatel JM, Soares S.

Front Microbiol. 2017 Sep 22;8:1790. doi: 10.3389/fmicb.2017.01790. eCollection 2017.

17.

Use of Traditional and Genetically Modified Probiotics in Human Health: What Does the Future Hold?

Bermúdez-Humarán LG, Langella P.

Microbiol Spectr. 2017 Sep;5(5). doi: 10.1128/microbiolspec.BAD-0016-2016. Review.

PMID:
28959936
18.

Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic.

Martín R, Miquel S, Benevides L, Bridonneau C, Robert V, Hudault S, Chain F, Berteau O, Azevedo V, Chatel JM, Sokol H, Bermúdez-Humarán LG, Thomas M, Langella P.

Front Microbiol. 2017 Jun 30;8:1226. doi: 10.3389/fmicb.2017.01226. eCollection 2017.

19.

Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis.

Carvalho RDO, do Carmo FLR, de Oliveira Junior A, Langella P, Chatel JM, Bermúdez-Humarán LG, Azevedo V, de Azevedo MS.

Front Microbiol. 2017 May 9;8:800. doi: 10.3389/fmicb.2017.00800. eCollection 2017. Review.

20.

Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria.

LeBlanc JG, Chain F, Martín R, Bermúdez-Humarán LG, Courau S, Langella P.

Microb Cell Fact. 2017 May 8;16(1):79. doi: 10.1186/s12934-017-0691-z. Review.

21.

Contribution of sortase SrtA2 to Lactobacillus casei BL23 inhibition of Staphylococcus aureus internalization into bovine mammary epithelial cells.

Souza RF, Jardin J, Cauty C, Rault L, Bouchard DS, Bermúdez-Humarán LG, Langella P, Monedero V, Seyffert N, Azevedo V, Le Loir Y, Even S.

PLoS One. 2017 Mar 21;12(3):e0174060. doi: 10.1371/journal.pone.0174060. eCollection 2017.

22.

Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis.

Carvalho RD, Breyner N, Menezes-Garcia Z, Rodrigues NM, Lemos L, Maioli TU, da Gloria Souza D, Carmona D, de Faria AM, Langella P, Chatel JM, Bermúdez-Humarán LG, Figueiredo HC, Azevedo V, de Azevedo MS.

Microb Cell Fact. 2017 Feb 13;16(1):27. doi: 10.1186/s12934-017-0624-x.

23.

Anti-cancer effect of lactic acid bacteria expressing antioxidant enzymes or IL-10 in a colorectal cancer mouse model.

Del Carmen S, de Moreno de LeBlanc A, Levit R, Azevedo V, Langella P, Bermúdez-Humarán LG, LeBlanc JG.

Int Immunopharmacol. 2017 Jan;42:122-129. doi: 10.1016/j.intimp.2016.11.017. Epub 2016 Nov 29.

PMID:
27912148
24.

Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice.

Martín R, Laval L, Chain F, Miquel S, Natividad J, Cherbuy C, Sokol H, Verdu EF, van Hylckama Vlieg J, Bermudez-Humaran LG, Smokvina T, Langella P.

Front Microbiol. 2016 May 6;7:608. doi: 10.3389/fmicb.2016.00608. eCollection 2016.

25.

A new lactobacilli in vivo expression system for the production and delivery of heterologous proteins at mucosal surfaces.

Allain T, Mansour NM, Bahr MM, Martin R, Florent I, Langella P, Bermúdez-Humarán LG.

FEMS Microbiol Lett. 2016 Jul;363(13). pii: fnw117. doi: 10.1093/femsle/fnw117. Epub 2016 May 1.

PMID:
27190148
26.

Gnotobiotic Rodents: An In Vivo Model for the Study of Microbe-Microbe Interactions.

Martín R, Bermúdez-Humarán LG, Langella P.

Front Microbiol. 2016 Mar 31;7:409. doi: 10.3389/fmicb.2016.00409. eCollection 2016. Review.

27.

Expression of fibronectin binding protein A (FnBPA) from Staphylococcus aureus at the cell surface of Lactococcus lactis improves its immunomodulatory properties when used as protein delivery vector.

Almeida JF, Breyner NM, Mahi M, Ahmed B, Benbouziane B, Boas PC, Miyoshi A, Azevedo V, Langella P, Bermúdez-Humarán LG, Chatel JM.

Vaccine. 2016 Mar 4;34(10):1312-8. doi: 10.1016/j.vaccine.2016.01.022. Epub 2016 Feb 5.

PMID:
26854905
28.

Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models.

Miquel S, Martín R, Lashermes A, Gillet M, Meleine M, Gelot A, Eschalier A, Ardid D, Bermúdez-Humarán LG, Sokol H, Thomas M, Theodorou V, Langella P, Carvalho FA.

Sci Rep. 2016 Jan 18;6:19399. doi: 10.1038/srep19399.

29.

Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer.

Lenoir M, Del Carmen S, Cortes-Perez NG, Lozano-Ojalvo D, Muñoz-Provencio D, Chain F, Langella P, de Moreno de LeBlanc A, LeBlanc JG, Bermúdez-Humarán LG.

J Gastroenterol. 2016 Sep;51(9):862-73. doi: 10.1007/s00535-015-1158-9. Epub 2016 Jan 9.

PMID:
26749362
30.

The secreted L-arabinose isomerase displays anti-hyperglycemic effects in mice.

Rhimi M, Bermudez-Humaran LG, Huang Y, Boudebbouze S, Gaci N, Garnier A, Gratadoux JJ, Mkaouar H, Langella P, Maguin E.

Microb Cell Fact. 2015 Dec 21;14:204. doi: 10.1186/s12934-015-0391-5.

31.

Identification of novel anti-inflammatory probiotic strains isolated from pulque.

Torres-Maravilla E, Lenoir M, Mayorga-Reyes L, Allain T, Sokol H, Langella P, Sánchez-Pardo ME, Bermúdez-Humarán LG.

Appl Microbiol Biotechnol. 2016 Jan;100(1):385-396.

PMID:
26476654
32.

Drying process strongly affects probiotics viability and functionalities.

Iaconelli C, Lemetais G, Kechaou N, Chain F, Bermúdez-Humarán LG, Langella P, Gervais P, Beney L.

J Biotechnol. 2015 Nov 20;214:17-26. doi: 10.1016/j.jbiotec.2015.08.022. Epub 2015 Aug 29.

PMID:
26325197
33.

Current Review of Genetically Modified Lactic Acid Bacteria for the Prevention and Treatment of Colitis Using Murine Models.

de Moreno de LeBlanc A, Del Carmen S, Chatel JM, Miyoshi A, Azevedo V, Langella P, Bermúdez-Humarán LG, LeBlanc JG.

Gastroenterol Res Pract. 2015;2015:146972. doi: 10.1155/2015/146972. Epub 2015 May 4. Review.

34.

Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.

Quévrain E, Maubert MA, Michon C, Chain F, Marquant R, Tailhades J, Miquel S, Carlier L, Bermúdez-Humarán LG, Pigneur B, Lequin O, Kharrat P, Thomas G, Rainteau D, Aubry C, Breyner N, Afonso C, Lavielle S, Grill JP, Chassaing G, Chatel JM, Trugnan G, Xavier R, Langella P, Sokol H, Seksik P.

Gut. 2016 Mar;65(3):415-425. doi: 10.1136/gutjnl-2014-307649. Epub 2015 Jun 4.

35.

Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii.

Miquel S, Leclerc M, Martin R, Chain F, Lenoir M, Raguideau S, Hudault S, Bridonneau C, Northen T, Bowen B, Bermúdez-Humarán LG, Sokol H, Thomas M, Langella P.

MBio. 2015 Apr 21;6(2). pii: e00300-15. doi: 10.1128/mBio.00300-15.

36.

Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci.

Bermúdez-Humarán LG, Motta JP, Aubry C, Kharrat P, Rous-Martin L, Sallenave JM, Deraison C, Vergnolle N, Langella P.

Microb Cell Fact. 2015 Feb 26;14:26. doi: 10.1186/s12934-015-0198-4.

37.

Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.

Martín R, Miquel S, Chain F, Natividad JM, Jury J, Lu J, Sokol H, Theodorou V, Bercik P, Verdu EF, Langella P, Bermúdez-Humarán LG.

BMC Microbiol. 2015 Mar 21;15:67. doi: 10.1186/s12866-015-0400-1.

38.

Intranasal administration with recombinant Lactococcus lactis expressing heme oxygenase-1 reduces hyperoxia-induced lung inflammation in rat pups.

Wu CY, Bermúdez-Humarán LG, Yue F, Li M, Zhang LP.

Biotechnol Lett. 2015 Jun;37(6):1203-11. doi: 10.1007/s10529-015-1795-3. Epub 2015 Apr 14.

PMID:
25868531
39.

Effect of iron on the probiotic properties of the vaginal isolate Lactobacillus jensenii CECT 4306.

Martín R, Sánchez B, Urdaci MC, Langella P, Suárez JE, Bermúdez-Humarán LG.

Microbiology. 2015 Apr;161(Pt 4):708-18. doi: 10.1099/mic.0.000044. Epub 2015 Jan 29.

PMID:
25635270
40.

Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice.

Laval L, Martin R, Natividad JN, Chain F, Miquel S, Desclée de Maredsous C, Capronnier S, Sokol H, Verdu EF, van Hylckama Vlieg JE, Bermúdez-Humarán LG, Smokvina T, Langella P.

Gut Microbes. 2015;6(1):1-9. doi: 10.4161/19490976.2014.990784. Epub 2015 Jan 14.

41.

Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model.

del Carmen S, Martín Rosique R, Saraiva T, Zurita-Turk M, Miyoshi A, Azevedo V, de Moreno de LeBlanc A, Langella P, Bermúdez-Humarán LG, LeBlanc JG.

J Clin Gastroenterol. 2014 Nov-Dec;48 Suppl 1:S12-7. doi: 10.1097/MCG.0000000000000235.

PMID:
25291117
42.

The dual role of MAPK pathway in the regulation of intestinal barrier: the role of the commensal bacterium Faecalibacterium prausnitzii on this regulation.

Martin R, Lenoir M, Chain F, Langella P, Bermúdez-Humarán LG.

Inflamm Bowel Dis. 2014 Jul;20(7):E17-8. doi: 10.1097/MIB.0000000000000070. No abstract available.

PMID:
24859300
43.

Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.

Martín R, Chain F, Miquel S, Natividad JM, Sokol H, Verdu EF, Langella P, Bermúdez-Humarán LG.

Hum Vaccin Immunother. 2014;10(6):1611-21. doi: 10.4161/hv.28549. Epub 2014 Apr 14.

44.

Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii.

Miquel S, Martín R, Bridonneau C, Robert V, Sokol H, Bermúdez-Humarán LG, Thomas M, Langella P.

Gut Microbes. 2014 Mar-Apr;5(2):146-51. doi: 10.4161/gmic.27651. Epub 2014 Jan 22.

45.

Gut ecosystem: how microbes help us.

Martín R, Miquel S, Ulmer J, Langella P, Bermúdez-Humarán LG.

Benef Microbes. 2014 Sep;5(3):219-33. doi: 10.3920/BM2013.0057. Review.

PMID:
24583612
46.

The role of metagenomics in understanding the human microbiome in health and disease.

Martín R, Miquel S, Langella P, Bermúdez-Humarán LG.

Virulence. 2014 Apr 1;5(3):413-23. doi: 10.4161/viru.27864. Epub 2014 Feb 11. Review.

47.

The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models.

Martín R, Chain F, Miquel S, Lu J, Gratadoux JJ, Sokol H, Verdu EF, Bercik P, Bermúdez-Humarán LG, Langella P.

Inflamm Bowel Dis. 2014 Mar;20(3):417-30. doi: 10.1097/01.MIB.0000440815.76627.64.

PMID:
24418903
48.

Genetically engineered immunomodulatory Streptococcus thermophilus strains producing antioxidant enzymes exhibit enhanced anti-inflammatory activities.

Del Carmen S, de Moreno de LeBlanc A, Martin R, Chain F, Langella P, Bermúdez-Humarán LG, LeBlanc JG.

Appl Environ Microbiol. 2014 Feb;80(3):869-77. doi: 10.1128/AEM.03296-13. Epub 2013 Nov 15.

49.

Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease.

Martín R, Miquel S, Ulmer J, Kechaou N, Langella P, Bermúdez-Humarán LG.

Microb Cell Fact. 2013 Jul 23;12:71. doi: 10.1186/1475-2859-12-71. Review.

50.

Engineering lactococci and lactobacilli for human health.

Bermúdez-Humarán LG, Aubry C, Motta JP, Deraison C, Steidler L, Vergnolle N, Chatel JM, Langella P.

Curr Opin Microbiol. 2013 Jun;16(3):278-83. doi: 10.1016/j.mib.2013.06.002. Epub 2013 Jul 11. Review.

PMID:
23850097

Supplemental Content

Loading ...
Support Center